StageZero Life Sciences Ltd T.SZLS

So much good news...

[gojotv!]

Since April 1st:

• StageZero launches Aristotle, the world's only highly accurate, non-invasive multi-cancer screening blood test amid a worldwide backlog in cancer tests due to the Covid crisis.
• SZLS announces a LOI to acquire "Health Clinics Limited" which includes "Care Oncology" telehealth services, a first foray into the growing multi-million dollar telehealth market.
• "Care Oncology" is given first priority to introduce Aristotle to its thousands of patients in the U.S. and U.K.
• Initial Aristotle deployment is confirmed in interview with SZLS CEO. Revenues will appear on the books for Q2.
• SZLS actively seeks more partnerships and affirms it is still offering its covid and cancer screening to employers. Some such projects appear to be underway.
• Covid testing revenues for Q1 remain relatively stable despite international travel shutdown in early 2021.
• Most accurate home PCR saliva tests for Covid now made more convenient and accessible to end users through Ichor distribution online and in Rexall pharmacies.
• Rexall in-house clinics and telehealth services a potential fit for SZLS long-term strategy.
• Europe announces imminent re-opening of its borders to international vaccinated travellers pending a negative PCR test, further expanding SZLS's revenue potential.
• Market movers express enthusiastic interest in StageZero in several online interviews and presentations.
• Price targets by Drolet and Clarus - $1.08 and $1.25 respectively.
• Share price currently near or at "oversold" following April "short attack" and apparent manipulation. A bargain.

Not bad for just about six weeks' work, eh?
Good luck to all longs!

[gojotv!]

It's pretty clear why analyst price targets stand at double the current share price...

[VerifiedUser123]

Oh yeah so clear! Let's not forget they cut it by more than half a month or so ago but oh yeah, table pounding buy. At this rate it'll almost be a triple!! Oh yeah! Get lost you clown, take your ritalin and slap yourself.

[gojotv!]

When I look at all the reasons StageZero stands to double in price (in accordance with analysts' targets) it makes me laugh that some investors are so allergic to making money! lol GLTA!

[gojotv!]

And the best news of all... Care Oncology share deal reveals their extreme confidence in the merger! Since they can't put those shares to market for months, Care is effectively saying, "We know we will grow the share value." And the fact that their base share value at acceptance was in the $1.30 range tells us that they intend to grow it from THERE! I love it when industry pros with

[gojotv!]

Good morning, bashers...! Is this what you were trying to bury?

[gojotv!]

If you're wondering why our basher is posting so desperately today, it's because he knows that analysts and market-makers are very excited about StageZero's future...! Price targets $1.08-$1.25! GLTA!!